SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership
SEC Accession No. 0000899140-07-000438
Filing Date
2007-02-22
Accepted
2007-02-22 13:47:48
Documents
4
Filing Date Changed
2007-02-22
Group Members
DANIEL S. LOEBTHIRD POINT OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING t022207b.txt SC 13D 27067
3 LETTER t022207c.txt EX-99.1 2888
4 JOINT FILING AGREEMENT t022207d.txt EX-99.2 2658
5 POA t022207e.txt EX-99.3 4608
  Complete submission text file 0000899140-07-000438.txt   39196
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

IRS No.: 000000000
Type: SC 13D | Act: 34 | File No.: 005-81801 | Film No.: 07641432
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D